Taxane resistance in breast cancer: mechanisms, predictive biomarkers and circumvention strategies.

Murray, S., Briasoulis, E., Linardou, H., Bafaloukos, D., Papadimitriou, C.·2012·Cancer Treatment Reviews
DOI 10.1016/j.ctrv.2012.02.011

Cited by (261)

Items 101–200 of 261

  1. Androgen receptor transcriptional activity and chromatin modifications on the ABCB1/MDR gene are critical for taxol resistance in ovarian cancer cells
    Nian‐Kang Sun, Abhidha Kohli, Shang‐Lang Huang, Ting‐Chang Chang, Chuck C.‐K. Chao · 2018 · Journal of Cellular Physiology
  2. Molecular characterisation of isogenic taxane resistant cell lines identify novel drivers of drug resistance
    J Kenicer, Melanie Spears, Nicola Lyttle, Karen J. Taylor, Linda Liao, Carrie Cunningham, Maryou B. K. Lambros, Alan G. Mackay, Cindy Q. Yao, Jorge Sergio Reis-Filho et al. · 2014 · BMC Cancer
  3. Expression of RET finger protein predicts chemoresistance in epithelial ovarian cancer
    麻衣子 堀尾, Takuya Kato, Shinji Mii, Atsushi Enomoto, Masato Asai, Naoya Asai, Yoshiki Murakumo, Kiyosumi Shibata, Fumitaka Kikkawa, Masahide Takahashi · 2012 · Cancer Medicine
  4. Applications of Nanosystems to Anticancer Drug Therapy (Part I. Nanogels, Nanospheres, Nanocapsules)
    Alan Talevi, Melisa E. Gantner, María Esperanza Ruiz · 2013 · Recent Patents on Anti-Cancer Drug Discovery
  5. Selective Aurora A-TPX2 Interaction Inhibitors Have In Vivo Efficacy as Targeted Antimitotic Agents
    Simon R. Stockwell, Duncan E. Scott, Gerhard Fischer, Estrella Guarino, Timothy P. C. Rooney, Tzu‐Shean Feng, Tommaso Moschetti, Rajavel Srinivasan, Esther Alza, Alice Asteian et al. · 2024 · Journal of Medicinal Chemistry
  6. Nested Case-control Study of Occupational Radiation Exposure and Breast and Esophagus Cancer Risk among Medical Diagnostic X Ray Workers in Jiangsu of China
    Fu-Ru Wang, Qiaoqiao Fang, Weiming Tang, Xiaosan Xu, Tanmay Mahapatra, Sanchita Mahapatra, Yufei Liu, Ningle Yu, Quanfu Sun · 2015 · Asian Pacific Journal of Cancer Prevention
  7. Role of tumor hypoxia in acquisition of resistance to microtubule-stabilizing drugs
    Viswanath Das, Jana Štěpánková, Marián Hajdúch, John Holmes Miller · 2015 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  8. A Promising Microtubule Inhibitor Deoxypodophyllotoxin Exhibits Better Efficacy to Multidrug-Resistant Breast Cancer than Paclitaxel via Avoiding Efflux Transport
    Xiaojie Zang, Guangji Wang, Qingyun Cai, Xiao Zheng, Jingwei Zhang, Qianying Chen, Baojin Wu, Xiong Zhu, Haiping Hao, Fang Zhou · 2018 · Drug Metabolism and Disposition
  9. CMINNs: Compartment model informed neural networks — Unlocking drug dynamics
    Nazanin Ahmadi Daryakenari, Shupeng Wang, George Em Karniadakis · 2024 · Computers in Biology and Medicine
  10. Mitotic cell death induction by targeting the mitotic spindle with tubulin-inhibitory indole derivative molecules
    Erica Di Cesare, Annalisa Verrico, Andrea Miele, Maria Giubettini, Paola Rovella, Antonio Coluccia, Valeria Famiglini, Giuseppe La Regina, Enrico Cundari, Romano Silvestri et al. · 2017 · Oncotarget
  11. Translational opportunities for broad‐spectrum natural phytochemicals and targeted agent combinations in breast cancer
    Lokesh Dalasanur Nagaprashantha, Ramesh Adhikari, Jyotsana Singhal, Shireen Chikara, Sanjay Awasthi, David A. Horne, Sharad S. Singhal · 2017 · International Journal of Cancer
  12. CETSA-based target engagement of taxanes as biomarkers for efficacy and resistance
    Anette Langebäck, Smaranda Bacanu, Henriette Laursen, Lisanne Mout, Takahiro Seki, Sigrun Erkens‐Schulze, Anderson Daniel Ramos, Anna Berggren, Yihai Cao, Johan Hartman et al. · 2019 · Scientific Reports
  13. Exploring Specific miRNA-mRNA Axes With Relationship to Taxanes-Resistance in Breast Cancer
    Danni Chen, Chang Bao, Feng Zhao, Haogang Yu, Guansheng Zhong, Liang Xu, Senxiang Yan · 2020 · Frontiers in Oncology
  14. Nsc23925 prevents the development of paclitaxel resistance by inhibiting the introduction of P ‐glycoprotein and enhancing apoptosis
    Xiaoqian Yang, Jacson K. Shen, Yan Gao, Yong Feng, Yichun Guan, Zhan Zhang, Henry J. Mankin, Francis John Hornicek, Zhenfeng Duan · 2015 · International Journal of Cancer
  15. Integrative transcriptomics-based identification of cryptic drivers of taxol-resistance genes in ovarian carcinoma cells: Analysis of the androgen receptor
    Nian‐Kang Sun, Shang‐Lang Huang, Hsing‐Pang Lu, Ting‐Chang Chang, Chuck C.‐K. Chao · 2015 · Oncotarget
  16. Leveraging Genomics, Transcriptomics, and Epigenomics to Understand the Biology and Chemoresistance of Ovarian Cancer
    Sandra Muñoz-Galván, Amancio Carnero · 2021 · Cancers
  17. Increased levels of choline metabolites are an early marker of docetaxel treatment response in BRCA1-mutated mouse mammary tumors: an assessment by ex vivo proton magnetic resonance spectroscopy
    Jack J.A. van Asten, Riyas Vettukattil, Tessa Buckle, Sven Rottenberg, Fijs W. B. van Leeuwen, Tone Frost Bathen, Arend Heerschap · 2015 · Journal of Translational Medicine
  18. A four‐gene signature predicts the efficacy of paclitaxel‐based neoadjuvant therapy in human epidermal growth factor receptor 2–negative breast cancer
    Zhi Li, Ye Zhang, Zhe Zhang, Zhenkun Zhao, Qingjie Lv · 2018 · Journal of Cellular Biochemistry
  19. Use of Cytotoxic Chemotherapy in Metastatic Breast Cancer: Putting Taxanes in Perspective
    Jasgit C. Sachdev, Mohammad Jahanzeb · 2015 · Clinical Breast Cancer
  20. Targeting the androgen receptor (AR) with AR degradation enhancer ASC-J9® led to increase docetaxel sensitivity via suppressing the p21 expression
    Jie Luo, Jing Tian, Fu-Ju Chou, Chang-Yi Lin, Emily Zixin Xing, Li Zuo, Yuanjie Niu, Shuyuan Yeh, Chawnshang Chang · 2018 · Cancer Letters
  21. Docetaxel Resistance in Breast Cancer: Current Insights and Future Directions
    Fátima Postigo-Corrales, Asunción Beltrán Videla, Antonio David Lazaro Sanchez, Ana María Hurtado, Pablo Conesa‐Zamora, Ana B. Arroyo, Ginés Luengo‐Gil · 2025 · International Journal of Molecular Sciences
  22. Tumor Glucose and Fatty Acid Metabolism in the Context of Anthracycline and Taxane-Based (Neo)Adjuvant Chemotherapy in Breast Carcinomas
    Anna‐Mária Tõkés, Stefan Vári-Kakas, Janina Kulka, Beáta Törőcsik · 2022 · Frontiers in Oncology
  23. Paclitaxel and Lapatinib dual loaded chitosan-coated PLGA nanoparticles enhance cytotoxicity by circumventing MDR1-mediated trastuzumab resistance in HER2 positive breast cancers: In-vitro and in-vivo studies
    Subrahmanyam Pitchika, Suvendu Kumar Sahoo · 2022 · Journal of Drug Delivery Science and Technology
  24. Glycolytic Inhibitors Potentiated the Activity of Paclitaxel and Their Nanoencapsulation Increased Their Delivery in a Lung Cancer Model
    Andrea Cunha, Ana Catarina Rocha, Flávia Barbosa, Ana Baião, Patrícia M. A. Silva, Bruno Filipe Carmelino Cardoso Sarmento, Odília Queirós · 2022 · Pharmaceutics
  25. Association of ABCB1, β tubulin I, and III with multidrug resistance of MCF7/DOC subline from breast cancer cell line MCF7
    Wentao Li, Baoping Zhai, Hui Zhi, Yuhong Li, Linjiao Jia, Chao Ding, Bin Zhang, Wei You · 2014 · Tumor Biology
  26. Chemoresistance to Cancer Treatment: Benzo-α-Pyrene as Friend or Foe?
    Kevin Dzobo, Naseeha Hassen, Dimakatso Alice Senthebane, Nicholas Ekow Thomford, Arielle Rowe, Hendrina Shipanga, Ambroise Wonkam, Mohamed Iqbal Parker, Shaheen Mowla, Collet Dandara · 2018 · Molecules
  27. The α7-nicotinic acetylcholine receptor mediates the sensitivity of gastric cancer cells to taxanes
    Chao-Chiang Tu, Chien‐Yu Huang, Wanli Cheng, Chin‐Sheng Hung, Uyanga Batzorig, Po‐Li Wei, Yu‐Jia Chang · 2015 · Tumor Biology
  28. Phosphatidylcholine-Based Nanoemulsions for Paclitaxel and a P-Glycoprotein Inhibitor Delivery and Breast Cancer Intraductal Treatment
    Giovanna Cassone Salata, Luciana B. Lopes · 2022 · Pharmaceuticals
  29. Repurposing of phentolamine as a potential anticancer agent against human castration-resistant prostate cancer: A central role on microtubule stabilization and mitochondrial apoptosis pathway
    Chen‐Hsun Ho, Jui‐Ling Hsu, Shih‐Ping Liu, Lih‐Ching Hsu, Wei-Ling Chang, Chuck C.‐K. Chao, Jih‐Hwa Guh · 2015 · The Prostate
  30. Distinct genetic alterations occur in ovarian tumor cells selected for combined resistance to carboplatin and docetaxel
    Stephen Armstrong, Rashmi Narendrula, Baoqing Guo, Amadeo Mark Parissenti, Katherine L McCallum, Stephanie Cull, Carita Lannér · 2012 · Journal of Ovarian Research
  31. Super Aqueous Solubility of Albendazole in β-Cyclodextrin for Parenteral Application in Cancer therapy
    Krishna Pillai, Javed Akhter, David Lawson Morris · 2017 · Journal of Cancer
  32. Differentially Expressed Mitochondrial Proteins in Human MCF7 Breast Cancer Cells Resistant to Paclitaxel
    Petr Daniel, Petr Halada, Michael Jelínek, Kamila Balušíková, Jan Kovár̆ · 2019 · International Journal of Molecular Sciences
  33. In Vitro Anticancer Activity of Novel Ciprofloxacin Mannich Base in Lung Adenocarcinoma and High-Grade Serous Ovarian Cancer Cell Lines via Attenuating MAPK Signaling Pathway
    Michael Atef Fawzy, Rania H. Abu-baih, Gamal El‐Din A. Abuo‐Rahma, Islam M. Abdel-Rahman, Azza A. K. El‐Sheikh, Maiiada Nazmy · 2023 · Molecules
  34. Shielding and nurturing: Fibronectin as a modulator of cancer drug resistance
    Faizah Farooq, Asif Amin, Umer Majeed Wani, Asif Lone, Raies Ahmad Qadri · 2023 · Journal of Cellular Physiology
  35. Spleen Tyrosine Kinase Confers Paclitaxel Resistance in Ovarian Cancer
    Wei Wei, Michael J. Birrer · 2015 · Cancer Cell
  36. Orally active microtubule-targeting agent, MPT0B271, for the treatment of human non-small cell lung cancer, alone and in combination with erlotinib
    A-C Tsai, C-Y Wang, J-P Liou, H-C Pai, C-J Hsiao, J-Y Chang, J-C Wang, C-M Teng, S-L Pan · 2014 · Cell Death and Disease
  37. STK39 promotes breast cancer invasion and metastasis by increasing SNAI1 activity upon phosphorylation
    Zhaoping Qiu, Bo Dong, Weijie Guo, Piotr G. Rychahou, Greg Longmore, Xiuwei H. Yang, Zhiyong Yu, Jiong Deng, Bernard Mark Evers, Yadi Wu · 2021 · Theranostics
  38. Microtubule Destabilizing Sulfonamides as an Alternative to Taxane-Based Chemotherapy
    Myriam González, María Ovejero-Sánchez, Alba Vicente‐Blázquez, Raquel Álvarez, Ana Belén Herrero, Manuel Medarde, Rogelio González‐Sarmiento, Rafael Peláez · 2021 · International Journal of Molecular Sciences
  39. Evaluation of the antimetastatic and anticancer activities of morin in HER2‑overexpressing breast cancer SK‑BR‑3 cells
    Kyu‐Shik Lee, Min‐Gu Lee, Kyung‐Soo Nam · 2021 · Oncology Reports
  40. Engineering Isoprenoid Biosynthesis inArtemisia annuaL. for the Production of Taxadiene: A Key Intermediate of Taxol
    Meiya Li, Fusheng Jiang, Xiangli Yu, Zhiqi Miao · 2015 · BioMed Research International
  41. Network-based approach to identify biomarkers predicting response and prognosis for HER2-negative breast cancer treatment with taxane-anthracycline neoadjuvant chemotherapy
    Cui Jiang, Shuo Wu, Lei Jiang, Zhichao Gao, Xiaorui Li, Yangyang Duan, Na Li, Tao Sun · 2019 · PeerJ
  42. Predictive value of microtubule-associated protein Tau in patients with recurrent and metastatic breast cancer treated with taxane-containing palliative chemotherapy
    Jie Zhou, Shikun Qian, Hongsheng Li, Weixing He, Xiaojun Tan, Qiong Zhang, Guodong Han, Guiquan Chen, Rongcheng Luo · 2015 · Tumor Biology
  43. Dicer Elicits Paclitaxel Chemosensitization and Suppresses Cancer Stemness in Breast Cancer by Repressing AXL
    Ting-Yu Chang, Hsin-An Chen, Ching‐Feng Chiu, Yi-Wen Chang, Tsang-Chih Kuo, Po‐Chun Tseng, Weu Wang, Mien‐Chie Hung, Jen-Liang Su · 2016 · Cancer Research · Retracted
  44. Roles of aldo-keto reductases 1B10 and 1C3 and ATP-binding cassette transporter in docetaxel tolerance
    Toshiyuki Matsunaga, Haruhi Saito, Satoshi Endo, Kazuhiro Iguchi, Midori Soda, Ossama A. L. El-Kabbani, Akira Hara, Akira Ikari · 2016 · Free Radical Research
  45. Pathways Linked to Cancer Chemoresistance and Their Targeting by Nutraceuticals
    Alok Chandra Bharti, Kanchan Vishnoi, Sukh Mahendra Singh, Bharat Bhushan Aggarwal · 2017 · Elsevier eBooks
  46. New Pharmacological Findings Linked to Biphenyl DHPMs, Kinesin Eg5 Ligands: Anticancer and Antioxidant Effects
    Itamar Luís Gonçalves, Liliana Rockenbach, Gabriela Göethel, Elisa Saüer, Luciano Porto Kagami, Gustavo Machado das Neves, Thaís Munhoz, Fabrício Figueiró, Solange Cristina García, Ana Maria Oliveira Battastini et al. · 2020 · Future Medicinal Chemistry
  47. Field template-based design and biological evaluation of new sphingosine kinase 1 inhibitors
    Heba A Alshaker, Shyam Srivats, Danielle C. Monteil, Qi Wang, Caroline M. R. Low, Dmitri Pchejetski · 2018 · Breast Cancer Research and Treatment
  48. Gonadotropin-Releasing Hormone Agonists Sensitize, and Resensitize, Prostate Cancer Cells to Docetaxel in a p53-Dependent Manner
    Roberta Manuela Moretti, Marina Montagnani Marelli, Deanne M. Taylor, Paolo G.V. Martini, Monica Marzagalli, Patrízia Limonta · 2014 · PLoS ONE
  49. Folate receptor-mediated delivery system based on chitosan coated polymeric nanoparticles for combination therapy of breast cancer
    Sajjad Jamali, Behzad Jamali, Fatemeh Abedi, Mohsen Firoozrai, Soodabeh Davaran, Sevil Vaghefi Moghaddam · 2024 · Journal of Biomaterials Science Polymer Edition
  50. Nogo-B receptor increases glycolysis and the paclitaxel resistance of estrogen receptor-positive breast cancer via the HIF-1α-dependent pathway
    Chang Liu, Sijie Li, Xiaoxiao Zhang, Chunxiang Jin, Baofeng Zhao, Liying Li, Qing Miao, Ying Hui Jin, Zhimin Fan · 2022 · Cancer Gene Therapy
  51. The N‐Hydroxymethyl Group as a Traceless Activating Group for the CAL‐B‐Catalysed Ring Cleavage of β‐Lactams: A Type of Two‐Step Cascade Reaction
    Enikő Forró, Zsolt Galla, Ferenc Fülöp · 2016 · European Journal of Organic Chemistry
  52. Nogo-B receptor increases the resistance of estrogen receptor positive breast cancer to paclitaxel
    Ying Hui Jin, Wenquan Hu, Tong Liu, Ujala Rana, Irene Aguilera‐Barrantes, Amanda L. Kong, Suresh N. Kumar, Bei Wang, Pin Gao, Xiang Wang et al. · 2018 · Cancer Letters
  53. Suppression of Long Non-Coding RNA Metastasis-Associated Lung Adenocarcinoma Transcript 1 (MALAT1) Potentiates Cell Apoptosis and Drug Sensitivity to Taxanes and Adriamycin in Breast Cancer
    Jie Yu, Taobo Jin, Tianya Zhang · 2020 · Medical Science Monitor
  54. AI-guided design of a CXCR4-targeted core-shell nanocarrier for co-delivery of berberine/paclitaxel in cancer therapy
    Yeonwoo Jang, Amal Babu, Sahil Chahal, Arathy Vasukutty, James Jaehyun Moon, In‐Kyu Park, Hansoo Park · 2025 · Journal of Nanobiotechnology
  55. P-Glycoprotein and Breast Cancer Resistance Protein in Canine Inflammatory and Noninflammatory Grade III Mammary Carcinomas
    Michela Levi, L. Peña, Ángela Alonso‐Diez, Barbara Brunetti, Luisa Vera Muscatello, Cinzia Benazzi, María Dolores Pérez Alenza, Giuseppe Sarli · 2019 · Veterinary Pathology
  56. Co-Adjuvant Therapy Efficacy of Catechin and Procyanidin B2 with Docetaxel on Hormone-Related Cancers In Vitro
    María Jesús Núñez-Iglesias, Silvia Novío, Carlota Garcı́a, María Elena Pérez-Muñuzuri, María-Carmen Martínez, J.L. Santiago, Susana Boso, Pilar Gago Montaña, Manuel Freire‐Garabal · 2021 · International Journal of Molecular Sciences
  57. Chemotherapeutic effects on breast tumor hemodynamics revealed by eigenspectra multispectral optoacoustic tomography (eMSOT)
    Evangelos Liapis, Angelos Karlas, Uwe Klemm, Vasilis Ntziachristos · 2021 · Theranostics
  58. Substituents at the C3′ and C3′N positions are critical for taxanes to overcome acquired resistance of cancer cells to paclitaxel
    Michael Jelínek, Kamila Balušíková, Petr Daniel, Vlasta Němcová‐Fürstová, Palani Kirubakaran, Martin Jaček, Longfei Wei, Xin Wang, Jiřı́ Vondrášek, Iwao Ojima et al. · 2018 · Toxicology and Applied Pharmacology
  59. Genome-scale knockout simulation and clustering analysis of drug-resistant breast cancer cells reveal drug sensitization targets
    JinA Lim, Hae Deok Jung, Soo Young Park, Moonhyeon Jeon, Da Sol Kim, Ryeongeun Cho, Dohyun Han, Han Suk Ryu, Yoosik Kim, Hyun Uk Kim · 2025 · Proceedings of the National Academy of Sciences
  60. The tubulysin analogue KEMTUB10 induces apoptosis in breast cancer cells via p53, Bim and Bcl-2
    Oluwafunmilayo F. Lamidi, Monica Sani, Paolo Lazzari, Matteo Zanda, Ian N. Fleming · 2015 · Journal of Cancer Research and Clinical Oncology
  61. Docetaxel suppresses immunotherapy efficacy of natural killer cells toward castration‐resistant prostate cancer cells via altering androgen receptor‐lectin‐like transcript 1 signals
    Min Moon Tang, Shenglin Gao, Lei Zhang, Bianjiang Liu, Jie Li, Zengjun Wang, Wei Zhang · 2020 · The Prostate
  62. Silymarin (Milk Thistle) can revoke liver enzyme changes during chemotherapy of breast cancer with Taxanes
    Fathollah Mohaghegh, Hassan Solhi, Amir Mohammad Kazemifar · 2015 · European Journal of Integrative Medicine
  63. Paclitaxel attenuates Bcl-2 resistance to apoptosis in breast cancer cells through an endoplasmic reticulum-mediated calcium release in a dosage dependent manner
    Zhi Zhong Pan, Lauren Gollahon · 2013 · Biochemical and Biophysical Research Communications
  64. Functionalized Lipid Nanocarriers for Simultaneous Delivery of Docetaxel and Tariquidar to Chemoresistant Cancer Cells
    Chang Hyun Kim, Sang Kil Lee, Ji Yeh Choi, Min Jeong Lyu, Hyun Min Jung, Yoon Tae Goo, Myung Joo Kang, Young Wook Choi · 2023 · Pharmaceuticals
  65. Advancements in targeting tumor suppressor genes (p53 and BRCA 1/2) in breast cancer therapy
    Chahat, Nidhi Nainwal, Yogesh Murti, Savita Yadav, Pramod Rawat, Sonia Dhiman, Bhupinder Kumar · 2024 · Molecular Diversity
  66. Breast cancer cells respond differently to docetaxel depending on their phenotype and on survivin upregulation
    Francesca De Iuliis, Gerardo Salerno, Anna Giuffrida, Bernardina Milana, Ludovica Taglieri, Giovanna Rubinacci, Sabrina Giantulli, Federica Terella, Ida Silvestri, Susanna Scarpa · 2015 · Tumor Biology
  67. Overexpression of microRNA-145 enhanced docetaxel sensitivity in breast cancer cells via inactivation of protein kinase B gamma-mediated phosphoinositide 3-kinase -protein kinase B pathway
    Ying Zhou, Wei Cai, Hailin Lu · 2022 · Bioengineered
  68. Nuclear Her2 contributes to paclitaxel resistance in breast cancer cells
    Bo Luo, Xinhong Wu, Yaojun Feng, Hongmei Zheng, Qu Zhang, Xinjun Liang, Dingfeng Huang, Juan Xu · 2021 · Anti-Cancer Drugs
  69. Taxane resistance in Breast Cancer
    2014 · Cancer Cell & Microenvironment
  70. Silencing of Taxol-Sensitizer Genes in Cancer Cells: Lack of Sensitization Effects
    Shang‐Lang Huang, Chuck C.‐K. Chao · 2015 · Cancers
  71. Identification of P-Glycoprotein and Transport Mechanism of Paclitaxel in Syncytiotrophoblast Cells
    Na-Young Lee, Ha-Eun Lee, Young‐Sook Kang · 2014 · Biomolecules & Therapeutics
  72. Indole Curcumin Reverses Multidrug Resistance by Reducing the Expression of ABCB1 and COX2 in Induced Multidrug Resistant Human Lung Cancer Cells
    Sankar Pajaniradje, Kumaravel Mohankumar, Rakesh Radhakrishnan, Shamim Akhtar Sufi, Srividya Subramanian, A. Parthiban, Surya Prakash Rao Hulluru, Rukkumani Rajagopalan · 2020 · Letters in Drug Design & Discovery
  73. Targeted Self-Emulsifying Drug Delivery Systems to Restore Docetaxel Sensitivity in Resistant Tumors
    Virginia Campani, Iris C. Salaroglio, Valeria Nele, Joanna Kopecka, Andreas Bernkop‐Schnürch, Chiara Riganti, Giuseppe De Rosa · 2022 · Pharmaceutics
  74. Combination therapy induces unfolded protein response and cytoskeletal rearrangement leading to mitochondrial apoptosis in prostate cancer
    Sandeep Kumar, Ajay Kumar Chaudhary, Rahul Kumar, Jordan O’Malley, Anna Dubrovska, Xinjiang Wang, Neelu Yadav, David W. Goodrich, Dhyan Chandra · 2016 · Molecular Oncology
  75. PTPRT Could Be a Treatment Predictive and Prognostic Biomarker for Breast Cancer
    Lun Li, Feng Xu, Pingfang Xie, Liqin Yuan, Meirong Zhou · 2021 · BioMed Research International
  76. Circular RNAs as novel biomarkers in triple-negative breast cancer: a systematic review
    Zahra Foruzandeh, Davood Ghavi, Farzaneh Sadeghi, Fatemeh Zeinali Sehrig, Mohammad Zaefizadeh, Yazdan Rahmati, Mohammad Reza Alivand · 2022 · Molecular Biology Reports
  77. CircRNA CircABCB1 Diminishes the Sensitivity of Breast Cancer Cells to Docetaxel by Sponging MiR-153-3p
    Jiaqi Liu, Linna Kong, Wenqing Bian, Xiaona Lin, Feifei Wei, Jun Chu · 2023 · The Tohoku Journal of Experimental Medicine
  78. Predictive value of the serum RASSF10 promoter methylation status in gastric cancer
    Yilin Hu, Peng Ma, Ying Feng, Peng Li, Hua Wang, Yibing Guo, Qinsheng Mao, Wanjiang Xue · 2019 · Journal of International Medical Research
  79. Polo-Like Kinase 1 Regulates Chromosomal Instability and Paclitaxel Resistance in Breast Cancer Cells
    Mingji Quan, Yumi Oh, Sung‐Yup Cho, Ju Hee Kim, Hyeong‐Gon Moon · 2022 · Journal of Breast Cancer
  80. Deciphering cellular and molecular mechanism of MUC13 mucin involved in cancer cell plasticity and drug resistance
    Shabnam Malik, Mohammed Sikander, Mohd Wahid, Anupam Dhasmana, Maryam Sarwat, Sheema Khan, Everardo Cobos, Murali Mohan Yallapu, Meena Jaggi, Subhash C. Chauhan · 2024 · Cancer and Metastasis Reviews
  81. Docetaxel and its potential in the treatment of refractory esophagogastric adenocarcinoma
    Hugo E. R. Ford, Ioannis Gounaris · 2015 · Therapeutic Advances in Gastroenterology
  82. UGCG promotes chemoresistance and breast cancer progression via NF-κB and Wnt/β-catenin pathway activation
    Long Li, Lei Wang, Yiran Liang, Fangzhou Ye, Yuhan Jin, Dan Luo, Xiaoyan Li, Yajie Wang, Yaming Li, Dianwen Han et al. · 2024 · Translational Oncology
  83. Preparation, stability and pharmacokinetics evaluation of lipid microspheres loading a promising antitumor candidate, Timataxel
    Yan Li, Haibing He, Qiao Wang, Xing Tang · 2016 · Asian Journal of Pharmaceutical Sciences
  84. S-72, a Novel Orally Available Tubulin Inhibitor, Overcomes Paclitaxel Resistance via Inactivation of the STING Pathway in Breast Cancer
    Zhenyan Hou, Songwen Lin, Tingting Du, Mingjin Wang, Weida Wang, Shen You, Nina Xue, Yichen Liu, Ming Ji, Heng Xu et al. · 2023 · Pharmaceuticals
  85. Comparing pyrotinib with trastuzumab and pertuzumab with trastuzumab for HER2-positive metastatic breast cancer: a retrospective, multicenter analysis
    Shuhui You, Yizhao Xie, Die Sang, Ting Luo, Peng Yuan, Fei Xu, Biyun Wang · 2023 · Frontiers in Endocrinology
  86. Activation of autophagy by stress-activated signals as a cellular self-defense mechanism against the cytotoxic effects of MBIC in human breast cancer cells in vitro
    Mohadeseh Hasanpourghadi, Nazia Binti Abdul Majid, Mohd Rais Mustafa · 2018 · Biochemical Pharmacology
  87. Protein Phosphatase 1H, Cyclin-Dependent Kinase Inhibitor p27, and Cyclin-Dependent Kinase 2 in Paclitaxel Resistance for Triple Negative Breast Cancers
    Saem Hur, Ju Hee Kim, Jihui Yun, Young Wook Ju, Jong Min Han, Woohang Heo, Kwangsoo Kim, Kyeonghun Jeong, Han‐Byoel Lee, Wonshik Han et al. · 2020 · Journal of Breast Cancer
  88. HSF1 at the crossroads of chemoresistance: from current insights to future horizons in cell death mechanisms
    Shruti Ghai, Rejina Shrestha, Kuo‐Hui Su · 2025 · Frontiers in Cell and Developmental Biology
  89. Targeting the breast tumor microenvironment by plant-derived products and their nanoformulations
    Hongpeng Zhang, Yanshu Li · 2024 · Journal of Drug Delivery Science and Technology
  90. Preformulation and development of chemically stable lipid emulsions containing a novel taxane derivative, TM‐2
    Jianli Shi, Xi Chen, Yuechen Gu, Xi Hu, Ling Zhang, Yan Li, Cuifang Cai, Xing Tang · 2014 · European Journal of Lipid Science and Technology
  91. The pterocarpanquinone LQB‑118 compound induces apoptosis of cytarabine‑resistant acute myeloid leukemia cells
    Thaís Hancio, Luciano Mazzoccoli, Gustavo Guimarães, Marcela Cristina Robaina, Bruna dos Santos Mendonça, Gabriela Nestal de Moraes, Bárbara da Costa Reis Monte-Mór, Luciana M. Gutiyama, Luíze De Carvalho, Chaquip D. Netto et al. · 2021 · International Journal of Oncology
  92. EphA8 inhibits cell apoptosis via AKT signaling and is associated with poor prognosis in breast cancer
    Guihua Wang, Kan Ni, Changjiang Gu, Jianfei Huang, Jing Chen, Xudong Wang, Qichao Ni · 2021 · Oncology Reports
  93. The Significant Role of Cyclin D1 in the Synergistic Growth-inhibitory Effect of Combined Therapy of Vandetanib with 5-Fluorouracil for Gastric Cancer
    Kazunori Yawata, Shinji Osada, Toshiyuki Tanahashi, Satoshi� Matsui, Yoshiyuki Sasaki, Yoshihiro Tanaka, Naoki Okumura, Nobuhisa Matsuhashi, Takao Takahashi, Kazuya Yamaguchi et al. · 2016 · Anticancer Research
  94. TaxKB: a knowledge base for new taxane-related drug discovery
    Kasi Murugan, Sangeetha Shanmugasamy, Saleh Al-Sohaibani, Naga Vignesh, Kandavel Palanikannan, Vimala Antonydhason, Gopal Ramesh Kumar · 2015 · BioData Mining
  95. Novel chemo-enzymatic route to a key intermediate for the taxol side-chain through enantioselective O-acylation. Unexpected acyl migration
    Enikő Forró, Zsolt Galla, Zala Nádasdi, Judit Árva, Ferenc Fülöp · 2015 · Journal of Molecular Catalysis B Enzymatic
  96. Multifunctional Pluronic nanomedicine: Bridging the gap between chemoresistance and effective cancer therapy
    Maliheh Hasannia, Mahdi Abounoori, Fatemeh Mahmoudian, Abbas Rahdar, Sonia Fathi-Karkan, Maryam Shirzad, Sadanand Pandey · 2026 · Journal of Drug Delivery Science and Technology
  97. Cancer Patient-Derived Cell-Based Models: Applications and Challenges in Functional Precision Medicine
    Jelena Dinić, Sofija Jovanović Stojanov, Miodrag Dragoj, Marija Grozdanić, Ana Podolski-Renić, Milica Pešić · 2024 · Life
  98. Association between Twist and multidrug resistance gene‑associated proteins in Taxol�‑resistant MCF‑7 cells and a 293 cell model of Twist overexpression
    Li Wang, Ruizhi Tan, Zhi‐Xia Zhang, Rui Yin, Yong‑Liang Zhang, Wei‐Jia Cui, Tao He · 2017 · Oncology Letters
  99. The Tumor Suppressor Role of the Ras Association Domain Family 10
    Yulong Hou, Shuofeng Li, Wei Du, Hailong Li, Rumin Wen · 2020 · Anti-Cancer Agents in Medicinal Chemistry
  100. Inhibition of Cytochrome P450 by Carbon Monoxide: Relevance to Drug Resistance in Human Breast Cancer Therapy
    Brian Kawahara, Pradip K. Mascharak · 2023 · Medical Research Archives